Industry News
Care Of Children With Cancer Affected By Language Barriers, Immigration Status Of Hispanic Caregivers
Oct 30, 2012
Language barriers and the immigration status of caregivers appear to impact the care of Hispanic children with cancer and affect the experience of the families within the medical system, according to data presented at the Fifth AACR Conference on The Science of Cancer Health Disparities, held here Oct. 27-30, 2012... Read More
Black Women At Increased Risk For Breast Cancer Mortality, Especially During First 3 Years Post-Diagnosis
Oct 30, 2012
Non-Hispanic black women diagnosed with breast cancer, specifically those with estrogen receptor-positive tumors, are at a significantly increased risk for breast cancer death compared with non-Hispanic white women. "This difference was greatest in the first three years after diagnosis," said Erica Warner, M.P.H., Sc.D., a postdoctoral fellow at Harvard School of Public Health in Boston, Mass... Read More
Mammography Facilities Less Accessible To Women In Less Affluent Areas Of Chicago
Oct 30, 2012
Women in socioeconomically disadvantaged and less affluent areas of Chicago were less likely to live near a mammography facility with various aspects of care compared with women in less socioeconomically disadvantaged and more affluent areas... Read More
Weight Link To Breast Cancer Survival Varies By Race/Ethnicity
Oct 30, 2012
An extreme body mass index or high waist-to-hip ratio, both measures of body fat, increased risk for mortality among patients with breast cancer, but this association varied by race/ethnicity, according to recently presented data. Marilyn L. Kwan, Ph.D., a research scientist in the Kaiser Permanente Northern California Division of Research in Oakland, Calif... Read More
Aggressive Tumors Most Likely In Minorities But They Are Less Likely To Get Radiation
Oct 30, 2012
Women with aggressive breast cancer were more likely to receive adjuvant chemotherapy, but at the expense of completing locoregional radiation therapy, according to recently presented data. This was especially true in minorities, who were the most likely to present with moderate- to high-grade and symptomatically detected tumors... Read More
Novel Genes Identified That May Drive Rare, Aggressive Form Of Uterine Cancer
Oct 30, 2012
Researchers have identified several genes that are linked to one of the most lethal forms of uterine cancer, serous endometrial cancer. The researchers describe how three of the genes found in the study are frequently altered in the disease, suggesting that the genes drive the development of tumors. The findings appear in the online issue of Nature Genetics... Read More
Details Of Doxorubicin Cardiotoxicity May Prevent Heart Failure From Chemotherapy
Oct 30, 2012
Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients... Read More
Nuclear Reprogramming And Pluripotent Stem Cells
Oct 30, 2012
The idea of taking a mature cell and removing its identity (nuclear reprogramming) so that it can then become any kind of cell, holds great promise for repairing damaged tissue or replacing bone marrow after chemotherapy. Hot on the heels of his recent Nobel prize Dr John B. Gurdon has published in BioMed Central's open access journal Epigenetics & Chromatin research showing that histone H3... Read More
Prostate Cancer Patients Find It Difficult To Understand Websites
Oct 30, 2012
Ninety million adults in the U.S. do not read at levels higher than high school, therefore, the NIH (National Institutes of Health) is suggesting that patient information material should be written on a 4th-6th grade level, according to a study conducted by researchers at Loyola University Medical Center and published in the Journal of Urology. The researchers have discovered that a mere 4... Read More
Genetic Predictors Of Fatigue For Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Oct 30, 2012
Researchers at Moffitt Cancer Center and the University of South Florida have found that men with prostate cancer who receive androgen deprivation therapy may predictably suffer from fatigue if they have single nucleotide polymorphisms in three pro-inflammatory genes. The discovery highlights the importance of personalized medicine, in which therapies are tailored to a patient's genetic profile... Read More
Previous Page Next Page